Drug Chatter -- Tracking biopharma stock chatter

Profile for Dicerna Pharmaceuticals, Inc. (DRNA)

« Back to company index

DRNA Chatter Timeline

Stock Ticker for DRNA

Most Active Tweeters for DRNA

UserTweets
@zerosum24 6
@RNAiAnalyst 6
@biotrader4gain 6
@WKRBNews 2
@portefeuillefun 2

Recent Tweets for DRNA

zerosum24 @zerosum24
$DRNA knocking on that door - https://t.co/efBQzSQZwg
July 19th 2017, 1:07pm
TheMarketsDaily @TheMarketsDaily
Dicerna Pharmaceuticals, Inc. $DRNA Lowered to “Sell” at Zacks Investment Research https://t.co/ugjWfhpy8K
July 19th 2017, 1:07pm
Optionsavvy @Optionsavvy
$DRNA is looking like it may try a low range break here https://t.co/3PzX7VNEcz
July 19th 2017, 8:07am
WKRBNews @WKRBNews
Dicerna Pharmaceuticals, Inc. $DRNA Lowered to Sell at Zacks Investment Research https://t.co/6q4mw42rRq
July 18th 2017, 10:07pm
WKRBNews @WKRBNews
Dicerna Pharmaceuticals, Inc. $DRNA Lowered to Sell at Zacks Investment Research https://t.co/RAhey1OkLE
July 18th 2017, 10:07pm
RatingsNetwork @RatingsNetwork
Dicerna Pharmaceuticals downgraded by Zacks Investment Research to sell. https://t.co/yZViDK6ulU $DRNA #DRNA
July 18th 2017, 10:07pm
AllDeltaNoTheta @AllDeltaNoTheta
Sold $DRNA 3.47 centuries later
July 18th 2017, 4:07pm
biotrader4gain @biotrader4gain
$DRNA needs some volume to break $3.50, tried once, maybe second attempt to break it
July 18th 2017, 12:07pm
biotrader4gain @biotrader4gain
RT @tgtxdough: $DRNA expects to submit a CTA in 4Q17 and initiate a Ph1 SAD/MAD trial in both HVs and PH patients in the UK and EU in early…
July 18th 2017, 11:07am
tgtxdough @tgtxdough
$DRNA expects to submit a CTA in 4Q17 and initiate a Ph1 SAD/MAD trial in both HVs and PH patients in the UK and EU in early 2018.
July 18th 2017, 11:07am
clayton_dd @clayton_dd
DRNA 3.41 Dicerna Pharmaceutic $DRNA Std Dev +2.05. DRNA Trading at 3.41 Day High 3.45 & Day Low 3.24 Change + https://t.co/GtEILf1Uam
July 18th 2017, 10:07am
Optionsavvy @Optionsavvy
$DRNA low range breakout is near. watching for a break of 3.5 on volume https://t.co/WS3z4Acnjx
July 18th 2017, 9:07am
RNAiAnalyst @RNAiAnalyst
@zerosum24 why? $DRNA certainly not interested in partnering ultra-orphan hyperoxalurias. in terms of platform vali… https://t.co/t98f9YcWho
July 18th 2017, 6:07am
biotrader4gain @biotrader4gain
$DRNA over $3.50 could get interesting https://t.co/4U5Wm7KRBQ
July 17th 2017, 9:07pm
portefeuillefun @portefeuillefun
RT @RNAiAnalyst: $DRNA file today's news under 'exceeding expectations'. Very nice work. I promise I won't tweet abt $DRNA today any more u…
July 17th 2017, 8:07pm
RNAiAnalyst @RNAiAnalyst
$DRNA file today's news under 'exceeding expectations'. Very nice work. I promise I won't tweet abt $DRNA today any more unless more news.
July 17th 2017, 3:07pm
biotrader4gain @biotrader4gain
$DRNA nice news this morning , setting up nicely. https://t.co/Ei8LHLz7cd
July 17th 2017, 3:07pm
biotrader4gain @biotrader4gain
RT @zerosum24: $DRNA breakout to watch for https://t.co/zH6LuTAtgc
July 17th 2017, 2:07pm
zerosum24 @zerosum24
$DRNA breakout to watch for https://t.co/zH6LuTAtgc
July 17th 2017, 2:07pm
RNAiAnalyst @RNAiAnalyst
What $ALNY has been up to while $DRNA found LDH to be better target than GO in primary hyperoxalurias. https://t.co/acSCrFMA7w
July 17th 2017, 12:07pm
portefeuillefun @portefeuillefun
RT @RNAiAnalyst: my bad: according to $DRNA presentation over weekend, PH1 represents 80% of primary hyperoxaluria cases: https://t.co/2Pd…
July 17th 2017, 11:07am
tanavoi373 @tanavoi373
RT @zerosum24: $DRNA news today makes a partnership a real possibility now before the end of the year. I would say chances just went up 60%
July 17th 2017, 11:07am
robnhoodtrader @robnhoodtrader
RT @zerosum24: yep $DRNA going A LOT HIGHER https://t.co/vQC50rH9JJ
July 17th 2017, 11:07am
zerosum24 @zerosum24
$DRNA news today makes a partnership a real possibility now before the end of the year. I would say chances just went up 60%
July 17th 2017, 11:07am
zerosum24 @zerosum24
yep $DRNA going A LOT HIGHER https://t.co/vQC50rH9JJ
July 17th 2017, 11:07am
Smallbios1 @Smallbios1
$DRNA this baby is worth more than $5 with today's positive development , @zerosum24
July 17th 2017, 11:07am
Valenti88539624 @Valenti88539624
RT @fascination_bio: $drna for the patient long term investor. like a new born baby in the portfolio.
July 17th 2017, 11:07am
RNAiAnalyst @RNAiAnalyst
@tanavoi373 that, plus less competitive heat from $ALNY and better target than before. $DRNA
July 17th 2017, 10:07am
tanavoi373 @tanavoi373
@RNAiAnalyst maybe $DRNA gets upgrades with higher pt's tomorrow and that moves the stock.
July 17th 2017, 10:07am
fascination_bio @fascination_bio
$drna for the patient long term investor. like a new born baby in the portfolio.
July 17th 2017, 10:07am
RNAiAnalyst @RNAiAnalyst
my bad: according to $DRNA presentation over weekend, PH1 represents 80% of primary hyperoxaluria cases: https://t.co/2Pdzvu4CRL
July 17th 2017, 10:07am
RNAiAnalyst @RNAiAnalyst
$DRNA! Respect: finds gene target for ALL types of primary hyperoxaluria. Also more reliable than GO for PH1. https://t.co/igfxNv9xvT $alny
July 17th 2017, 10:07am
theLDMicro @theLDMicro
Dicerna $DRNA Expands Lead GalXC(TM) Development Program to Encompass All Forms of Primary Hyperoxaluria (PH) a... https://t.co/BkyXUMHkVz
July 17th 2017, 10:07am
Briefingcom @Briefingcom
$DRNA: Dicerna Pharmaceuticals presents new preclinical data suggesting the potential utility of DCR-PHXC for... https://t.co/QYOGvk0Lcr
July 17th 2017, 9:07am
StockNewsNow @StockNewsNow
$DRNA Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (PH) and... https://t.co/4y9jgEkkgE
July 17th 2017, 8:07am
tickerws @tickerws
$DRNA presents preclinical data on DCR-PHXC https://t.co/YdHQHGeOXf
July 17th 2017, 7:07am
Onellymr @Onellymr
$DRNA Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (... https://t.co/8Pu4QQLnmN
July 17th 2017, 7:07am
biotrader4gain @biotrader4gain
RT @stockboardinc: $DRNA Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (P... - https://t.…
July 17th 2017, 7:07am
stockboardinc @stockboardinc
$DRNA Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (P... - https://t.co/qMzxqH4Ctj
July 17th 2017, 7:07am
newswelldone @newswelldone
$DRNA: Dicerna Expands Lead GalXC™ Development Program to …: https://t.co/mBIxb2inPw
July 17th 2017, 7:07am
WatchlistN @WatchlistN
Dicerna Pharmaceuticals $DRNA Receives Daily News Impact Rating of 0.31 https://t.co/YagCQxyrQK
July 14th 2017, 3:07pm
marketexclusive @marketexclusive
DICERNA PHARMACEUTICALS, INC. (NASDAQ:DRNA) Files An 8-K Submission of Matters to a Vote of Security Holders https://t.co/itsQ9Rl8Ly $DRNA
July 12th 2017, 4:07pm
confcalltran @confcalltran
Submission of Matters to a Vote of Security Holders https://t.co/siTJInlxMn $DRNA
July 12th 2017, 4:07pm
popastock @popastock
RT @zerosum24: $AFMD and $DRNA have similar setups.. which one will go first? Both are breakout teases, but they won't tease forever me thi…
July 11th 2017, 2:07pm
zerosum24 @zerosum24
$AFMD and $DRNA have similar setups.. which one will go first? Both are breakout teases, but they won't tease forever me thinks.
July 11th 2017, 1:07pm
emq_news @emq_news
Very Favorable Media Coverage Likely to Impact Dicerna Pharmaceuticals $DRNA Stock Price https://t.co/m0BKHgn7oq
July 11th 2017, 9:07am
TickerReport @TickerReport
Very Favorable Media Coverage Likely to Impact Dicerna Pharmaceuticals $DRNA Stock Price https://t.co/YOrzfuw8Zk
July 11th 2017, 9:07am
TickerReport @TickerReport
Very Favorable Media Coverage Likely to Impact Dicerna Pharmaceuticals $DRNA Stock Price https://t.co/O58FjHNP5X
July 11th 2017, 9:07am
AllDeltaNoTheta @AllDeltaNoTheta
$DRNA broke through a couple MAs and positive MACD. Setting up for a breakout.
July 6th 2017, 12:07pm
zerosum24 @zerosum24
$DRNA setting up for a breakout soon - https://t.co/rhn4VBaUvR
July 6th 2017, 11:07am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.